Zynerba Pharmaceuticals マネジメント
マネジメント 基準チェック /34
現在、CEO に関する十分な情報がありません。
主要情報
Armando Anido
最高経営責任者
US$1.9m
報酬総額
| CEO給与比率 | 33.6% |
| CEO在任期間 | 9yrs |
| CEOの所有権 | 1.9% |
| 経営陣の平均在職期間 | 6.8yrs |
| 取締役会の平均在任期間 | 8.2yrs |
経営陣の近況
Recent updates
Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Deliver On Growth Plans?
Mar 01
Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Invest In Growth?
Nov 11Zynerba stock rises on US patent for cannabidiol Zygel's use for Fragile X syndrome
Oct 06Zynerba Pharmaceuticals GAAP EPS of -$0.24 misses by $0.01
Aug 10We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
Jul 22Zynerba inks equity funding contract of up to $20M with Lincoln Park Capital
Jul 21Here's Why We're Watching Zynerba Pharmaceuticals' (NASDAQ:ZYNE) Cash Burn Situation
Mar 23We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
Dec 02We Think Zynerba Pharmaceuticals (NASDAQ:ZYNE) Can Afford To Drive Business Growth
May 27Zynerba Pharma shares slip 10% on Zygel update in Fragile X syndrome
Dec 17Is Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Invest In Growth?
Nov 23
Zynerba Pharmaceuticals EPS beats by $0.12
Nov 09Zynerba Zygel Remains A Huge Part Of The Company's Pipeline Despite Setback
Oct 29CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$38m |
| Mar 31 2023 | n/a | n/a | -US$37m |
| Dec 31 2022 | US$2m | US$633k | -US$35m |
| Sep 30 2022 | n/a | n/a | -US$36m |
| Jun 30 2022 | n/a | n/a | -US$38m |
| Mar 31 2022 | n/a | n/a | -US$38m |
| Dec 31 2021 | US$2m | US$603k | -US$37m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$37m |
| Mar 31 2021 | n/a | n/a | -US$47m |
| Dec 31 2020 | US$1m | US$585k | -US$51m |
| Sep 30 2020 | n/a | n/a | -US$52m |
| Jun 30 2020 | n/a | n/a | -US$45m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$1m | US$568k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$30m |
| Jun 30 2019 | n/a | n/a | -US$36m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$2m | US$568k | -US$40m |
| Sep 30 2018 | n/a | n/a | -US$40m |
| Jun 30 2018 | n/a | n/a | -US$41m |
| Mar 31 2018 | n/a | n/a | -US$37m |
| Dec 31 2017 | US$2m | US$552k | -US$32m |
| Sep 30 2017 | n/a | n/a | -US$31m |
| Jun 30 2017 | n/a | n/a | -US$28m |
| Mar 31 2017 | n/a | n/a | -US$26m |
| Dec 31 2016 | US$901k | US$536k | -US$23m |
報酬と市場: Armandoの 総報酬 ($USD 1.88M ) は、 US市場 ($USD 647.72K ) の同規模の企業の平均を上回っています。
報酬と収益: Armandoの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Armando Anido (65 yo)
9yrs
在職期間
US$1,881,402
報酬
Mr. Armando Anido, MBA, has been the Chairman and Chief Executive Officer of Zynerba Pharmaceuticals, Inc. since October 2014. Mr. Anido has been an Independent Director of SCYNEXIS, Inc. since January 21,...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 9yrs | US$1.88m | 1.94% $ 1.3m | |
| President | 9yrs | US$1.38m | 1.18% $ 775.1k | |
| CFO & VP of Corporate Development (Leave of Absence) | 7.1yrs | US$1.26m | 0.75% $ 491.5k | |
| VP, Corporate Controller & Interim CFO | 6.6yrs | データなし | 0.17% $ 111.2k | |
| Chief Legal Officer & Corporate Secretary | 1.7yrs | データなし | 0.45% $ 295.1k | |
| Vice President of Human Resources | 5.6yrs | データなし | データなし |
6.8yrs
平均在職期間
59yo
平均年齢
経験豊富な経営陣: ZYNEの経営陣は経験豊富で経験豊富です（平均在職期間は6.8年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman & CEO | 9yrs | US$1.88m | 1.94% $ 1.3m | |
| Independent Director | 8.2yrs | US$107.50k | 0.15% $ 98.5k | |
| Independent Director | 8.2yrs | US$105.00k | 0.15% $ 98.5k | |
| Lead Independent Director | 8.2yrs | US$135.00k | 0.15% $ 98.5k | |
| Independent Director | 5.5yrs | US$102.50k | 0.16% $ 105.0k | |
| Independent Director | 8.2yrs | US$110.00k | 0.15% $ 98.5k | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | 8yrs | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | 7yrs | データなし | データなし | |
| Independent Director | 4.7yrs | US$100.00k | 0.15% $ 98.5k | |
| Member of Scientific Advisory Board | no data | データなし | データなし |
8.2yrs
平均在職期間
65yo
平均年齢
経験豊富なボード: ZYNEの 取締役会 は 経験豊富 であると考えられます ( 8.2年の平均在任期間)。